InsiderClue
← All stocks

Harmony Biosciences Holdings, Inc.

HRMY Net selling
CIK 0001802665 #1965 in the set updated 17 Sep 2026
Bought (120 mo)
$12.54M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$536.33M
$2.16M on a plan · $30.07M straight out of an exercise
Sold at will
$504.11M
104 of 183 sales
Net
−$523.80M
−$491.57M against sales at will

By person

13 insiders · 192 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Valor IV Pharma Holdings, LLC entity
10% owner
—
$139.39M (2)
−$139.39M
0
0.0000%
$0.00
—
Marshman Fund Trust II entity
10% owner
$8.15M (1)
$139.39M (2)
−$131.24M
6,051,120
10.39%
$260.81M
−3.7%
Wicki Andreas
Director
—
$127.30M (29)
−$127.30M
2,147,943
3.69%
$92.58M
−53.7%
Nielsen Jack
Director
$1.21M (6)
$96.52M (68)
−$95.31M
2,613,726
4.49%
$112.66M
−39.8%
Dierks Jeffrey
CHIEF COMMERCIAL OFFICER
—
$11.90M (38) scheduled
−$11.90M
0
0.0000%
$0.00
−100.0%
Jacobs John C
PRESIDENT, CEO
—
$8.78M (16) scheduled
−$8.78M
0
0.0000%
$0.00
—
Dayno Jeffrey M.
PRESIDENT, CEO
—
$5.43M (13) scheduled
−$5.43M
7,346
0.0126%
$316.62K
—
Kapadia Sandip
CHIEF FINANCIAL OFFICER
—
$3.89M (9) scheduled
−$3.89M
24,521
0.0421%
$1.06M
+2,452,000%
Novo Holdings A/S entity
10% owner
$3.18M (1)
—
+$3.18M
4,409,803
7.57%
$190.07M
—
Serafin Andrew
CHIEF STRATEGY OFFICER
—
$2.29M (2) scheduled
−$2.29M
1,474
0.0025%
$63.53K
—
Budur Kumar
CHIEF MEDICAL OFFICER
—
$1.45M (4) scheduled
−$1.45M
13,115
0.0225%
$565.27K
+1,205%
ARONIN JEFFREY S
Director
—
—
—
251,922
0.4326%
$10.86M
—
Zaeske Adam H.
CHIEF COMMERCIAL OFFICER
—
—
—
4,327
0.0074%
$186.50K
—

Individual transactions

71
Insider
Date
Role
Action
Shares
Price
Amount
Budur Kumar
8 Sep 2026
CHIEF MEDICAL OFFICER
Sold after exercise
22,954
$43.10
$989.35K
Budur Kumar
8 Sep 2026
CHIEF MEDICAL OFFICER
Sold after exercise
1,000
$42.79
$42.79K
Budur Kumar
8 Sep 2026
CHIEF MEDICAL OFFICER
Sold after exercise
4,500
$42.25
$190.11K
Dayno Jeffrey M.
12 Dec 2025
PRESIDENT, CEO
Sold after exercise
5,933
$40.11
$237.96K
Dayno Jeffrey M.
12 Dec 2025
PRESIDENT, CEO
Sold after exercise
20,000
$40.11
$802.15K
Kapadia Sandip
5 Dec 2025
CHIEF FINANCIAL OFFICER
Sold after exercise
20,000
$39.54
$790.90K
Dierks Jeffrey
3 Mar 2025
CHIEF COMMERCIAL OFFICER
Sold after exercise
500
$33.23
$16.62K
Dierks Jeffrey
3 Mar 2025
CHIEF COMMERCIAL OFFICER
Sold after exercise
4,369
$32.61
$142.47K
Dierks Jeffrey
24 Jan 2025
CHIEF COMMERCIAL OFFICER
Sold after exercise
5,125
$37.87
$194.10K
Dierks Jeffrey
24 Jan 2025
CHIEF COMMERCIAL OFFICER
Sold after exercise
8,000
$36.94
$295.53K
Dierks Jeffrey
21 Jan 2025
CHIEF COMMERCIAL OFFICER
Sold after exercise
1,123
$40.00
$44.92K
Kapadia Sandip
21 Jan 2025
CHIEF FINANCIAL OFFICER
Sold after exercise
25,000
$40.18
$1.00M
Dayno Jeffrey M.
21 Jan 2025
PRESIDENT, CEO
Sold after exercise
19,293
$40.13
$774.25K
Dierks Jeffrey
16 Jan 2025
CHIEF COMMERCIAL OFFICER
Sold after exercise
29,475
$37.41
$1.10M
Dierks Jeffrey
15 Jan 2025
CHIEF COMMERCIAL OFFICER
Sold after exercise
10,507
$37.01
$388.84K
Dierks Jeffrey
13 Jan 2025
CHIEF COMMERCIAL OFFICER
Sold after exercise
7,180
$37.04
$265.95K
Dierks Jeffrey
29 Oct 2024
CHIEF COMMERCIAL OFFICER
Sold after exercise
21,496
$40.47
$870.02K
Dierks Jeffrey
1 Oct 2024
CHIEF COMMERCIAL OFFICER
Sold after exercise
400
$40.19
$16.08K
Dierks Jeffrey
30 Sep 2024
CHIEF COMMERCIAL OFFICER
Sold after exercise
35,846
$40.03
$1.43M
Dierks Jeffrey
27 Sep 2024
CHIEF COMMERCIAL OFFICER
Sold after exercise
200
$40.05
$8.01K
Dierks Jeffrey
15 Mar 2024
CHIEF COMMERCIAL OFFICER
Sold after exercise
11,979
$32.00
$383.33K
Dierks Jeffrey
8 Mar 2024
CHIEF COMMERCIAL OFFICER
Sold after exercise
194
$32.00
$6.21K
Serafin Andrew
2 Dec 2022
CHIEF STRATEGY OFFICER
Sold after exercise
920
$60.71
$55.85K
Serafin Andrew
2 Dec 2022
CHIEF STRATEGY OFFICER
Sold after exercise
37,080
$60.12
$2.23M
Dayno Jeffrey M.
3 Nov 2022
CHIEF MEDICAL OFFICER
Sold after exercise
15,000
$60.02
$900.33K
Dayno Jeffrey M.
1 Nov 2022
CHIEF MEDICAL OFFICER
Sold after exercise
15,000
$55.10
$826.56K
Dierks Jeffrey
3 Oct 2022
CHIEF COMMERCIAL OFFICER
Sold after exercise
2,791
$45.47
$126.91K
Dierks Jeffrey
3 Oct 2022
CHIEF COMMERCIAL OFFICER
Sold after exercise
9,382
$44.45
$417.00K
Dierks Jeffrey
22 Aug 2022
CHIEF COMMERCIAL OFFICER
Sold after exercise
2,321
$47.56
$110.40K
Dierks Jeffrey
22 Aug 2022
CHIEF COMMERCIAL OFFICER
Sold after exercise
26,650
$46.95
$1.25M
Jacobs John C
15 Aug 2022
PRESIDENT, CEO
Sold after exercise
909
$51.76
$47.05K
Jacobs John C
15 Aug 2022
PRESIDENT, CEO
Sold after exercise
39,091
$51.05
$2.00M
Jacobs John C
15 Jun 2022
President, CEO
Sold after exercise
800
$46.13
$36.91K
Jacobs John C
15 Jun 2022
President, CEO
Sold after exercise
14,200
$45.38
$644.37K
Jacobs John C
13 Jun 2022
President, CEO
Sold after exercise
15,197
$44.53
$676.68K
Jacobs John C
13 Jun 2022
President, CEO
Sold after exercise
9,803
$43.63
$427.74K
Dierks Jeffrey
1 Apr 2022
Chief Commercial Officer
Sold after exercise
7,706
$49.87
$384.28K
Dierks Jeffrey
1 Apr 2022
Chief Commercial Officer
Sold after exercise
6,765
$49.36
$333.89K
Jacobs John C
16 Mar 2022
President, CEO
Sold after exercise
15,000
$45.32
$679.82K
Jacobs John C
14 Mar 2022
President, CEO
Sold after exercise
930
$43.47
$40.43K
Jacobs John C
14 Mar 2022
President, CEO
Sold after exercise
11,614
$42.66
$495.47K
Jacobs John C
14 Mar 2022
President, CEO
Sold after exercise
12,456
$42.06
$523.87K
Dierks Jeffrey
1 Mar 2022
Chief Commercial Officer
Sold after exercise
4,869
$40.04
$194.96K
Dierks Jeffrey
28 Feb 2022
Chief Commercial Officer
Sold after exercise
10,041
$40.00
$401.65K
Dierks Jeffrey
17 Feb 2022
Chief Commercial Officer
Sold after exercise
4,259
$40.02
$170.42K
Dierks Jeffrey
16 Feb 2022
Chief Commercial Officer
Sold after exercise
4,259
$40.05
$170.59K
Dierks Jeffrey
6 Jan 2022
Chief Commercial Officer
Sold after exercise
424
$41.23
$17.48K
Dierks Jeffrey
6 Jan 2022
Chief Commercial Officer
Sold after exercise
4,302
$40.53
$174.38K
Dierks Jeffrey
6 Jan 2022
Chief Commercial Officer
Sold after exercise
1,399
$39.60
$55.40K
Jacobs John C
4 Jan 2022
President, CEO
Sold after exercise
18,053
$45.15
$815.05K
Jacobs John C
3 Jan 2022
President, CEO
Sold after exercise
10,647
$45.17
$480.94K
Jacobs John C
27 Dec 2021
President, CEO
Sold after exercise
1,300
$45.03
$58.54K
Jacobs John C
13 Dec 2021
President, CEO
Sold after exercise
11,860
$38.43
$455.78K
Jacobs John C
13 Dec 2021
President, CEO
Sold after exercise
13,140
$38.02
$499.63K
Dierks Jeffrey
1 Nov 2021
Chief Commercial Officer
Sold after exercise
2,946
$42.44
$125.01K
Dierks Jeffrey
1 Nov 2021
Chief Commercial Officer
Sold after exercise
7,054
$41.36
$291.72K
Dayno Jeffrey M.
19 Oct 2021
Chief Medical Officer
Sold after exercise
4,101
$43.77
$179.51K
Dayno Jeffrey M.
19 Oct 2021
Chief Medical Officer
Sold after exercise
14,099
$43.13
$608.04K
Dayno Jeffrey M.
6 Oct 2021
Chief Medical Officer
Sold after exercise
1,800
$40.10
$72.18K
Jacobs John C
13 Sep 2021
President, CEO
Sold after exercise
25,000
$35.93
$898.26K
Dayno Jeffrey M.
7 Sep 2021
Chief Medical Officer
Sold after exercise
10,000
$37.58
$375.78K
Dierks Jeffrey
7 Sep 2021
Chief Commercial Officer
Sold after exercise
5,000
$37.00
$185.00K
Dierks Jeffrey
1 Sep 2021
Chief Commercial Officer
Sold after exercise
3,302
$34.26
$113.12K
Dierks Jeffrey
1 Sep 2021
Chief Commercial Officer
Sold after exercise
6,698
$33.30
$223.01K
Dierks Jeffrey
27 Aug 2021
Chief Commercial Officer
Sold after exercise
3,400
$35.18
$119.60K
Dayno Jeffrey M.
27 Aug 2021
Chief Medical Officer
Sold after exercise
7,841
$35.16
$275.70K
Dierks Jeffrey
26 Aug 2021
Chief Commercial Officer
Sold after exercise
1,600
$35.01
$56.02K
Dayno Jeffrey M.
26 Aug 2021
Chief Medical Officer
Sold after exercise
2,159
$35.01
$75.58K
Dayno Jeffrey M.
10 Aug 2021
Chief Medical Officer
Sold after exercise
9,950
$30.21
$300.63K
Dayno Jeffrey M.
22 Jul 2021
Chief Medical Officer
Sold after exercise
50
$30.00
$1.50K
Dierks Jeffrey
15 Jun 2021
Chief Commercial Officer
Sold after exercise
15,000
$31.32
$469.81K
Show all 192 transactions →

What was left out

Form 4 filings counted 181
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 71
Sales at will 104
Transactions with no price 0
Shares from compensation/vesting 28,717,343
Sales filed before the plan box existed 97
History held since 20 Aug 2020